Advertise  Subscription



   Site Map
   Front Page
   Nation/Politics
   World
   Commentary
   Editorials/Op-Ed
   Metropolitan
   Sports
   Business
   Special Reports
   Technology
   Entertainment
   Books
   Food
   Wash. Weekend
   Travel
   Family Times
   Culture, etc.
   Civil War
   Weather
   Corrections
   Photo Gallery
   TWT Insider
Stock Quotes
Symbol Lookup
   Classifieds
   Home Guide
   Auto Weekend
   Employment
   Health
   Services Directory
   Market Place
   Tourist Guide
   Holiday Gift Guide
   International Reports
   Archive
   Subscription Services
   Advertise
   About TWT
   Contact Us
   TWT Gift Shop
   Insight Magazine
   The World & I
   National Weekly
   Middle East Times
   Tiempos del Mundo
   Segye Ilbo
   Segye Times USA
   Chongyohak Shinmun
   Sekai Nippo
   Wash. Golf Monthly
   World Peace Herald

 

Leukemia

Take a free interactive course on CML

Featured Article

Cancer Drug Studied in Children with Rare Form of Leukemia

Read Article

The drug, STI-571, also known as Gleevec, was approved for the treatment of chronic myeloid leukemia, or CML, one of the four main types of leukemia.

 Current Topics in Leukemia Library

Video - Taking Part in CML Trials Transcript
Video - New Strategies for Hard to Treat CML Transcript
Video - Emerging Therapies in CML Transcript
Video - Monitoring Therapy in Chronic Myeloid Leukemia Transcript
Ask Your Doctor - About Molecular-Targeted Therapies
Video - CML Therapy Update Transcript
Article - Cancer Drug Studied in Children with Rare Form of Leukemia
Article - New Drug for Rare, Hard-to-Treat Cancers
Did You Know - The number of cells containing the genetic defect in some leukemias can be reduced
Article - New Stem Cell Transplant Brings Hope to Children with Leukemia
Ask Your Doctor - About Treatment Issues in Chronic Myelogenous Leukemia
Article - Do Smoking Dads-to-Be Increase Leukemia Risk?
Article - Drug Errors Common in ALL Patients

Related Topics



Health Poll

Do you currently have health insurance?
Advertising
 
   

All site contents copyright © News World Communications, Inc.
Privacy Policy
 
Health
Nation/Politics World Commentary Classifieds